408 related articles for article (PubMed ID: 15474625)
21. Interpreting clinical trials of diabetic dyslipidaemia: new insights.
Wierzbicki AS
Diabetes Obes Metab; 2009 Mar; 11(3):261-70. PubMed ID: 17645560
[TBL] [Abstract][Full Text] [Related]
22. Strategies for management and treatment of dyslipidemia in HIV/AIDS.
Sax PE
AIDS Care; 2006 Feb; 18(2):149-57. PubMed ID: 16338773
[TBL] [Abstract][Full Text] [Related]
23. Achievement of optimal combined lipid values in a managed care setting: is a new treatment paradigm needed?
Sarawate CA; Cziraky MJ; Stanek EJ; Willey VJ; Corbelli JC; Charland SL
Clin Ther; 2007 Jan; 29(1):196-209. PubMed ID: 17379061
[TBL] [Abstract][Full Text] [Related]
24. APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study.
Dufouil C; Richard F; Fiévet N; Dartigues JF; Ritchie K; Tzourio C; Amouyel P; Alpérovitch A
Neurology; 2005 May; 64(9):1531-8. PubMed ID: 15883313
[TBL] [Abstract][Full Text] [Related]
25. Diabetic dyslipidemia: a practical guide to therapy.
Tovar JM; Bazaldua OV; Loffredo A
J Fam Pract; 2008 Jun; 57(6):377-88. PubMed ID: 18544321
[TBL] [Abstract][Full Text] [Related]
26. [Continuing care of patients with cardiovascular risk in general practice: patients with dyslipidemia and their care].
Jancsó Z; Varga Z; Simay A; Ilyés I
Orv Hetil; 2005 Dec; 146(52):2629-33. PubMed ID: 16468604
[TBL] [Abstract][Full Text] [Related]
27. Utility of currently available modes of therapy in reaching lipid goals.
Spratt KA; Denke MA
J Am Osteopath Assoc; 2004 Sep; 104(9 Suppl 7):S14-6. PubMed ID: 15467019
[TBL] [Abstract][Full Text] [Related]
28. Combination therapy with statins and omega-3 fatty acids.
Nambi V; Ballantyne CM
Am J Cardiol; 2006 Aug; 98(4A):34i-38i. PubMed ID: 16919515
[TBL] [Abstract][Full Text] [Related]
29. Ezetimibe is effective when added to maximally tolerated lipid lowering therapy in patients with HIV.
Bennett MT; Johns KW; Bondy GP
Lipids Health Dis; 2007 Jun; 6():15. PubMed ID: 17565701
[TBL] [Abstract][Full Text] [Related]
30. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease.
Staels B; Maes M; Zambon A
Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):542-53. PubMed ID: 18628776
[TBL] [Abstract][Full Text] [Related]
31. [HIV infection, antiretroviral therapy, and endothelium].
Hürlimann D; Weber R; Enseleit F; Lüscher TF
Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
[TBL] [Abstract][Full Text] [Related]
32. HIV protease inhibitors and dyslipidemia.
Clotet B; Negredo E
AIDS Rev; 2003; 5(1):19-24. PubMed ID: 12875104
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
Sharma R; Mahajan M; Singh B; Bal BS; Kant R
J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006
[TBL] [Abstract][Full Text] [Related]
34. Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients.
Calza L; Manfredi R; Chiodo F
J Antimicrob Chemother; 2004 Jan; 53(1):10-4. PubMed ID: 14645323
[TBL] [Abstract][Full Text] [Related]
35. [Favorable effects of decreasing lipids in patients with diabetes mellitus].
Gouni-Berthold I; Krone W
Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S252-4. PubMed ID: 17139581
[TBL] [Abstract][Full Text] [Related]
36. Lipid profiles of Thai adult HIV-infected patients receiving protease inhibitors.
Hiransuthikul N; Hiransuthikul P; Kanasook Y
Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):69-77. PubMed ID: 17539249
[TBL] [Abstract][Full Text] [Related]
37. Effects of a stanol-enriched diet on plasma cholesterol and triglycerides in patients treated with statins.
Castro Cabezas M; de Vries JH; Van Oostrom AJ; Iestra J; van Staveren WA
J Am Diet Assoc; 2006 Oct; 106(10):1564-9. PubMed ID: 17000189
[TBL] [Abstract][Full Text] [Related]
38. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile.
Meas T; Laloi-Michelin M; Virally M; Peynet J; Giraudeaux V; Kévorkian JP; Guillausseau PJ
Eur J Intern Med; 2009 Mar; 20(2):197-200. PubMed ID: 19327612
[TBL] [Abstract][Full Text] [Related]
39. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
[TBL] [Abstract][Full Text] [Related]
40. Lipids in type 2 diabetes.
Laakso M
Semin Vasc Med; 2002 Feb; 2(1):59-66. PubMed ID: 16222596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
